-
1
-
-
0028972701
-
Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity
-
Cummings, B. J.; Cotman, C. W. Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity Lancet 1995, 346 (8989) 1524-1528
-
(1995)
Lancet
, vol.346
, Issue.8989
, pp. 1524-1528
-
-
Cummings, B.J.1
Cotman, C.W.2
-
2
-
-
0038117796
-
Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline
-
Naslund, J.; Haroutunian, V.; Mohs, R.; Davis, K. L.; Davies, P.; Greengard, P.; Buxbaum, J. D. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline JAMA, J. Am. Med. Assoc. 2000, 283 (12) 1571-1577
-
(2000)
JAMA, J. Am. Med. Assoc.
, vol.283
, Issue.12
, pp. 1571-1577
-
-
Naslund, J.1
Haroutunian, V.2
Mohs, R.3
Davis, K.L.4
Davies, P.5
Greengard, P.6
Buxbaum, J.D.7
-
3
-
-
0021256895
-
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
-
Glenner, G. G.; Wong, C. W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein Biochem. Biophys. Res. Commun. 1984, 120 (3) 885-890
-
(1984)
Biochem. Biophys. Res. Commun.
, vol.120
, Issue.3
, pp. 885-890
-
-
Glenner, G.G.1
Wong, C.W.2
-
4
-
-
0012510759
-
Amyloid plaque core protein in Alzheimer disease and Down syndrome
-
Masters, C. L.; Simms, G.; Weinman, N. A.; Multhaup, G.; McDonald, B. L.; Beyreuther, K. Amyloid plaque core protein in Alzheimer disease and Down syndrome Proc. Natl. Acad. Sci. U.S.A. 1985, 82 (12) 4245-4249
-
(1985)
Proc. Natl. Acad. Sci. U.S.A.
, vol.82
, Issue.12
, pp. 4245-4249
-
-
Masters, C.L.1
Simms, G.2
Weinman, N.A.3
Multhaup, G.4
McDonald, B.L.5
Beyreuther, K.6
-
5
-
-
0030971789
-
Disaggregation of Alzheimer β-amyloid by site-directed mAb
-
Solomon, B.; Kippel, R.; Frankel, D.; Hanan-Aharon, E. Disaggregation of Alzheimer β-amyloid by site-directed mAb Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 4109-4112
-
(1997)
Proc. Natl. Acad. Sci. U.S.A.
, vol.94
, pp. 4109-4112
-
-
Solomon, B.1
Kippel, R.2
Frankel, D.3
Hanan-Aharon, E.4
-
6
-
-
77949300796
-
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: A phase 2, double-blind, placebo-controlled, ascending-dose study
-
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study Lancet Neurol. 2010, 9, 363-372
-
(2010)
Lancet Neurol.
, vol.9
, pp. 363-372
-
-
Rinne, J.O.1
Brooks, D.J.2
Rossor, M.N.3
Fox, N.C.4
Bullock, R.5
Klunk, W.E.6
Mathis, C.A.7
Blennow, K.8
Barakos, J.9
Okello, A.A.10
Rodriguez Martinez De Llano, S.11
Liu, E.12
Koller, M.13
Gregg, K.M.14
Schenk, D.15
Black, R.16
Grundman, M.17
-
7
-
-
84855780598
-
Gantenerumab: A novel human anti-Aβ antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β
-
Bohrmann, B.; Baumann, K.; Benz, J.; Gerber, F.; Huber, W.; Knolfach, F.; Messer, J.; Oroszlan, K.; Rachenberger, R.; Richter, W. F.; Rothe, C.; Urban, M.; Bardroff, M.; Winter, M.; Nordstedt, C.; Loetscher, H. Gantenerumab: A novel human anti-Aβ antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β J. Alzheimer's Dis. 2012, 28, 49-69
-
(2012)
J. Alzheimer's Dis.
, vol.28
, pp. 49-69
-
-
Bohrmann, B.1
Baumann, K.2
Benz, J.3
Gerber, F.4
Huber, W.5
Knolfach, F.6
Messer, J.7
Oroszlan, K.8
Rachenberger, R.9
Richter, W.F.10
Rothe, C.11
Urban, M.12
Bardroff, M.13
Winter, M.14
Nordstedt, C.15
Loetscher, H.16
-
8
-
-
33947686655
-
Fusion antibody for Alzheimer's disease with bidirectional transport across the blood-brain barrier and abeta fibril disaggregation
-
Boado, R. J.; Zhang, Y.; Xia, C. F.; Pardridge, W. M. Fusion antibody for Alzheimer's disease with bidirectional transport across the blood-brain barrier and abeta fibril disaggregation Bioconjugate Chem. 2007, 18 (2) 447-455
-
(2007)
Bioconjugate Chem.
, vol.18
, Issue.2
, pp. 447-455
-
-
Boado, R.J.1
Zhang, Y.2
Xia, C.F.3
Pardridge, W.M.4
-
9
-
-
76249087751
-
Pharmacokinetics and brain uptake of a genetically engineered bifunctional fusion antibody targeting the mouse transferrin receptor
-
Boado, R. J.; Zhou, Q. H.; Lu, J. Z.; Hui, E. K.; Pardridge, W. M. Pharmacokinetics and brain uptake of a genetically engineered bifunctional fusion antibody targeting the mouse transferrin receptor Mol. Pharmaceutics 2010, 7, 237-244
-
(2010)
Mol. Pharmaceutics
, vol.7
, pp. 237-244
-
-
Boado, R.J.1
Zhou, Q.H.2
Lu, J.Z.3
Hui, E.K.4
Pardridge, W.M.5
-
10
-
-
0035283233
-
Mediated efflux of IgG molecules from brain to blood across the blood-brain barrier
-
Zhang, Y.; Pardridge, W. M. Mediated efflux of IgG molecules from brain to blood across the blood-brain barrier J. Neuroimmunol. 2001, 114, 168-172
-
(2001)
J. Neuroimmunol.
, vol.114
, pp. 168-172
-
-
Zhang, Y.1
Pardridge, W.M.2
-
11
-
-
0036079202
-
Expression of the neonatal Fc receptor (FcRn) at the blood-brain barrier
-
Schlachetzki, F.; Zhu, C.; Pardridge, W. M. Expression of the neonatal Fc receptor (FcRn) at the blood-brain barrier J. Neurochem. 2002, 81, 203-206
-
(2002)
J. Neurochem.
, vol.81
, pp. 203-206
-
-
Schlachetzki, F.1
Zhu, C.2
Pardridge, W.M.3
-
12
-
-
77951086901
-
Safety and changes in plasma and cerebrospinal fluid amyloid β after a single administration of an amyloid β monoclonal antibody in subjects with Alzheimer disease
-
Siemers, E. R.; Friedrich, S.; Dean, R. A.; Gonzales, C. R.; Farlow, M. R.; Paul, S. M.; DeMattos, R. B. Safety and changes in plasma and cerebrospinal fluid amyloid β after a single administration of an amyloid β monoclonal antibody in subjects with Alzheimer disease Clin. Neuropharmacol. 2010, 33, 67-73
-
(2010)
Clin. Neuropharmacol.
, vol.33
, pp. 67-73
-
-
Siemers, E.R.1
Friedrich, S.2
Dean, R.A.3
Gonzales, C.R.4
Farlow, M.R.5
Paul, S.M.6
Demattos, R.B.7
-
13
-
-
77953282150
-
A single ascending dose study of bapineuzumab in patients with Alzheimer disease
-
Black, R. S.; Sperling, R. A.; Safirstein, B.; Motter, R. N.; Pallay, A.; Nichols, A.; Grundman, M. A single ascending dose study of bapineuzumab in patients with Alzheimer disease Alzheimer Dis. Assoc. Disord. 2010, 24, 198-203
-
(2010)
Alzheimer Dis. Assoc. Disord.
, vol.24
, pp. 198-203
-
-
Black, R.S.1
Sperling, R.A.2
Safirstein, B.3
Motter, R.N.4
Pallay, A.5
Nichols, A.6
Grundman, M.7
-
14
-
-
0033835996
-
Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
-
Bard, F.; Cannon, C.; Barbour, R.; Burke, R. L.; Games, D.; Grajeda, H.; Guido, T.; Hu, K.; Huang, J.; Johnson-Wood, K.; Khan, K.; Kholodenko, D.; Lee, M.; Lieberburg, I.; Motter, R.; Nguyen, M.; Soriano, F.; Vasquez, N.; Weiss, K.; Welch, B.; Seubert, P.; Schenk, D.; Yednock, T. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease Nat. Med. 2000, 6, 916-919
-
(2000)
Nat. Med.
, vol.6
, pp. 916-919
-
-
Bard, F.1
Cannon, C.2
Barbour, R.3
Burke, R.L.4
Games, D.5
Grajeda, H.6
Guido, T.7
Hu, K.8
Huang, J.9
Johnson-Wood, K.10
Khan, K.11
Kholodenko, D.12
Lee, M.13
Lieberburg, I.14
Motter, R.15
Nguyen, M.16
Soriano, F.17
Vasquez, N.18
Weiss, K.19
Welch, B.20
Seubert, P.21
Schenk, D.22
Yednock, T.23
more..
-
15
-
-
79952932382
-
Receptor-mediated Abeta amyloid antibody targeting to Alzheimer's disease mouse brain
-
Zhou, Q. H.; Fu, A.; Boado, R. J.; Hui, E. K.-H.; Lu, J. Z.; Pardridge, W. M. Receptor-mediated Abeta amyloid antibody targeting to Alzheimer's disease mouse brain Mol. Pharmaceutics 2011, 8, 280-285
-
(2011)
Mol. Pharmaceutics
, vol.8
, pp. 280-285
-
-
Zhou, Q.H.1
Fu, A.2
Boado, R.J.3
Hui, E.K.-H.4
Lu, J.Z.5
Pardridge, W.M.6
-
16
-
-
84875803152
-
Pharmacokinetics and brain uptake of an IgG-TNF decoy receptor fusion protein following intravenous, intraperitoneal, and subcutaneous administration in mice
-
Sumbria, R. K.; Zhou, Q.-H.; Hui, E.K.-W.; Lu, J. Z.; Boado, R. J.; Pardridge, W. M. Pharmacokinetics and brain uptake of an IgG-TNF decoy receptor fusion protein following intravenous, intraperitoneal, and subcutaneous administration in mice Mol. Pharmaceutics 2013, 10, 1425-1431
-
(2013)
Mol. Pharmaceutics
, vol.10
, pp. 1425-1431
-
-
Sumbria, R.K.1
Zhou, Q.-H.2
Hui, E.K.-W.3
Lu, J.Z.4
Boado, R.J.5
Pardridge, W.M.6
-
17
-
-
42449097992
-
Determination of primary structure and microheterogeneity of a β-amyloid plaque-specific antibody using high-performance LC-tandem mass spectrometry
-
Perdivara, I.; Deterding, L.; Moise, A.; Tomer, K. B.; Przybylski, M. Determination of primary structure and microheterogeneity of a β-amyloid plaque-specific antibody using high-performance LC-tandem mass spectrometry Anal. Bioanal. Chem. 2008, 391, 325-336
-
(2008)
Anal. Bioanal. Chem.
, vol.391
, pp. 325-336
-
-
Perdivara, I.1
Deterding, L.2
Moise, A.3
Tomer, K.B.4
Przybylski, M.5
-
18
-
-
80355132694
-
Detection of neuritic plaques in Alzheimer's disease mouse model
-
DOI: 10.3791/2831
-
Ly, P. T.; Cai, F.; Song, W. Detection of neuritic plaques in Alzheimer's disease mouse model. J. Visualized Exp. 2011, 53, DOI: 10.3791/2831.
-
(2011)
J. Visualized Exp.
, Issue.53
-
-
Ly, P.T.1
Cai, F.2
Song, W.3
-
19
-
-
25144503548
-
Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls
-
Kumar-Singh, S.; Pirici, D.; McGowan, E.; Serneels, S.; Ceuterick, C.; Hardy, J.; Duff, K.; Dickson, D.; Van Broeckhoven, C. Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls Am. J. Pathol. 2005, 167, 527-43
-
(2005)
Am. J. Pathol.
, vol.167
, pp. 527-543
-
-
Kumar-Singh, S.1
Pirici, D.2
McGowan, E.3
Serneels, S.4
Ceuterick, C.5
Hardy, J.6
Duff, K.7
Dickson, D.8
Van Broeckhoven, C.9
-
20
-
-
79952775194
-
Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-β immunotherapy
-
Wang, A.; Das, P.; Switzer, R. C.; Golde, T. E.; Jankowsky, J. L. Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-β immunotherapy J. Neurosci. 2011, 31, 4124-4136
-
(2011)
J. Neurosci.
, vol.31
, pp. 4124-4136
-
-
Wang, A.1
Das, P.2
Switzer, R.C.3
Golde, T.E.4
Jankowsky, J.L.5
-
21
-
-
0035877756
-
Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695
-
Chishti, M. A.; Yang, D. S.; Janus, C.; Phinney, A. L.; Horne, P.; Pearson, J.; Strome, R.; Zuker, N.; Loukides, J.; French, J.; Turner, S.; Lozza, G.; Grilli, M.; Kunicki, S.; Morissette, C.; Paquette, J.; Gervais, F.; Bergeron, C.; Fraser, P. E.; Carlson, G. A.; George-Hyslop, P. S.; Westaway, D. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695 J. Biol. Chem. 2001, 276, 21562-21570
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 21562-21570
-
-
Chishti, M.A.1
Yang, D.S.2
Janus, C.3
Phinney, A.L.4
Horne, P.5
Pearson, J.6
Strome, R.7
Zuker, N.8
Loukides, J.9
French, J.10
Turner, S.11
Lozza, G.12
Grilli, M.13
Kunicki, S.14
Morissette, C.15
Paquette, J.16
Gervais, F.17
Bergeron, C.18
Fraser, P.E.19
Carlson, G.A.20
George-Hyslop, P.S.21
Westaway, D.22
more..
-
22
-
-
19944431509
-
Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid β
-
Racke, M. M.; Boone, L. I.; Hepburn, D. L.; Parsadainian, M.; Bryan, M. T.; Ness, D. K.; Piroozi, K. S.; Jordan, W. H.; Brown, D. D.; Hoffman, W. P.; Holtzman, D. M.; Bales, K. R.; Gitter, B. D.; May, P. C.; Paul, S. M.; DeMattos, R. B. Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid β J. Neurosci. 2005, 25, 629-636
-
(2005)
J. Neurosci.
, vol.25
, pp. 629-636
-
-
Racke, M.M.1
Boone, L.I.2
Hepburn, D.L.3
Parsadainian, M.4
Bryan, M.T.5
Ness, D.K.6
Piroozi, K.S.7
Jordan, W.H.8
Brown, D.D.9
Hoffman, W.P.10
Holtzman, D.M.11
Bales, K.R.12
Gitter, B.D.13
May, P.C.14
Paul, S.M.15
Demattos, R.B.16
-
23
-
-
33745001453
-
Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice
-
Wilcock, D. M.; Alamed, J.; Gottschall, P. E.; Grimm, J.; Rosenthal, A.; Pons, J.; Ronan, V.; Symmonds, K.; Gordon, M. N.; Morgan, D. Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice J. Neurosci. 2006, 26, 5340-5346
-
(2006)
J. Neurosci.
, vol.26
, pp. 5340-5346
-
-
Wilcock, D.M.1
Alamed, J.2
Gottschall, P.E.3
Grimm, J.4
Rosenthal, A.5
Pons, J.6
Ronan, V.7
Symmonds, K.8
Gordon, M.N.9
Morgan, D.10
-
24
-
-
0032483505
-
Beta-amyloid (1-42) peptide impairs blood-brain barrier function after intracarotid infusion in rats
-
Jancsó, G.; Domoki, F.; Sántha, P.; Varga, J.; Fischer, J.; Orosz, K.; Penke, B.; Becskei, A.; Dux, M.; Tóth, L. Beta-amyloid (1-42) peptide impairs blood-brain barrier function after intracarotid infusion in rats Neurosci. Lett. 1998, 253, 139-141
-
(1998)
Neurosci. Lett.
, vol.253
, pp. 139-141
-
-
Jancsó, G.1
Domoki, F.2
Sántha, P.3
Varga, J.4
Fischer, J.5
Orosz, K.6
Penke, B.7
Becskei, A.8
Dux, M.9
Tóth, L.10
-
25
-
-
0033528254
-
Intravascular infusions of soluble β-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhage
-
Su, G. C.; Arendash, G. W.; Kalaria, R. N.; Bjugstad, K. B.; Mullan, M. Intravascular infusions of soluble β-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhage Brain Res. 1999, 818, 105-117
-
(1999)
Brain Res.
, vol.818
, pp. 105-117
-
-
Su, G.C.1
Arendash, G.W.2
Kalaria, R.N.3
Bjugstad, K.B.4
Mullan, M.5
-
26
-
-
65649148265
-
Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice
-
Wilcock, D. M.; Colton, C. A. Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice CNS Neurol. Disord. Drug Targets 2009, 8, 50-64
-
(2009)
CNS Neurol. Disord. Drug Targets
, vol.8
, pp. 50-64
-
-
Wilcock, D.M.1
Colton, C.A.2
-
27
-
-
84862777153
-
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: A retrospective analysis
-
Sperling, R.; Salloway, S.; Brooks, D. J.; Tampieri, D.; Barakos, J.; Fox, N. C.; Raskind, M.; Sabbagh, M.; Honig, L. S.; Porsteinsson, A. P.; Lieberburg, I.; Arrighi, H. M.; Morris, K. A.; Lu, Y.; Liu, E.; Gregg, K. M.; Brashear, H. R.; Kinney, G. G.; Black, R.; Grundman, M. Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis Lancet Neurol. 2012, 11, 241-249
-
(2012)
Lancet Neurol.
, vol.11
, pp. 241-249
-
-
Sperling, R.1
Salloway, S.2
Brooks, D.J.3
Tampieri, D.4
Barakos, J.5
Fox, N.C.6
Raskind, M.7
Sabbagh, M.8
Honig, L.S.9
Porsteinsson, A.P.10
Lieberburg, I.11
Arrighi, H.M.12
Morris, K.A.13
Lu, Y.14
Liu, E.15
Gregg, K.M.16
Brashear, H.R.17
Kinney, G.G.18
Black, R.19
Grundman, M.20
more..
-
28
-
-
84863115941
-
Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab
-
Ostrowitzki, S.; Deptula, D.; Thurfjell, L.; Barkhof, F.; Bohrmann, B.; Brooks, D. J.; Klunk, W. E.; Ashford, E.; Yoo, K.; Xu, Z. X.; Loetscher, H.; Santarelli, L. Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab Arch. Neurol. 2012, 69, 198-207
-
(2012)
Arch. Neurol.
, vol.69
, pp. 198-207
-
-
Ostrowitzki, S.1
Deptula, D.2
Thurfjell, L.3
Barkhof, F.4
Bohrmann, B.5
Brooks, D.J.6
Klunk, W.E.7
Ashford, E.8
Yoo, K.9
Xu, Z.X.10
Loetscher, H.11
Santarelli, L.12
-
29
-
-
84866538826
-
Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic mice
-
Bard, F.; Fox, M.; Friedrich, S.; Seubert, P.; Schenk, D.; Kinney, G. G.; Yednock, T. Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic mice Exp. Neurol. 2012, 238, 38-43
-
(2012)
Exp. Neurol.
, vol.238
, pp. 38-43
-
-
Bard, F.1
Fox, M.2
Friedrich, S.3
Seubert, P.4
Schenk, D.5
Kinney, G.G.6
Yednock, T.7
-
30
-
-
0002595302
-
Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse
-
Lee, H. J.; Engelhardt, B.; Lesley, J.; Bickel, U.; Pardridge, W. M. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse J. Pharmacol. Exp. Ther. 2000, 292, 1048-1052
-
(2000)
J. Pharmacol. Exp. Ther.
, vol.292
, pp. 1048-1052
-
-
Lee, H.J.1
Engelhardt, B.2
Lesley, J.3
Bickel, U.4
Pardridge, W.M.5
-
31
-
-
0025051493
-
Benzodiazepine concentrations in brain directly reflect receptor occupancy: Studies of diazepam, lorezepam, and oxazepam
-
Greenblatt, D. J.; Sethy, V. H. Benzodiazepine concentrations in brain directly reflect receptor occupancy: studies of diazepam, lorezepam, and oxazepam Psychopharmacology 1990, 102, 373-378
-
(1990)
Psychopharmacology
, vol.102
, pp. 373-378
-
-
Greenblatt, D.J.1
Sethy, V.H.2
-
32
-
-
79959444718
-
Chronic dosing of mice with a transferrin receptor monoclonal antibody-GDNF fusion protein
-
Zhou, Q.-H.; Boado, R. J.; Lu, J. Z.; Hui, E.K.-W.; Pardridge, W. M. Chronic dosing of mice with a transferrin receptor monoclonal antibody-GDNF fusion protein Drug Metab. Dispos. 2011, 39, 1149-1154
-
(2011)
Drug Metab. Dispos.
, vol.39
, pp. 1149-1154
-
-
Zhou, Q.-H.1
Boado, R.J.2
Lu, J.Z.3
Hui, E.K.-W.4
Pardridge, W.M.5
|